[
  {
    "date": "2022-12-31",
    "symbol": "ENLV",
    "period": "FY",
    "cashandcashequivalentsatcarryingvalue": 49945000,
    "depositsassetscurrent": 299000,
    "prepaidexpenseandotherassetscurrent": 2086000,
    "assetscurrent": 52330000,
    "propertyplantandequipmentnet": 9875000,
    "otherassets": 5437000,
    "assetsnoncurrent": 15312000,
    "assets": 67642000,
    "accountspayabletradecurrent": 113000,
    "accountspayableandotheraccruedliabilitiescurrent": 99000,
    "liabilitiescurrent": 6607000,
    "otherlongtermdebt": 4194000,
    "liabilitiesnoncurrent": 4194000,
    "liabilities": 10801000,
    "commonstockvalue": 2117000,
    "additionalpaidincapital": 136648000,
    "accumulatedothercomprehensiveincomelossforeigncurrencytranslationadjustmentnetoftax": 1101000,
    "retainedearningsaccumulateddeficit": -83025000,
    "stockholdersequity": -83025000,
    "liabilitiesandstockholdersequity": 67642000,
    "commonstockparorstatedvaluepershare": 0.4,
    "commonstocksharesauthorized": 45000000,
    "commonstocksharesissued": 18421852,
    "commonstocksharesoutstanding": 18421852,
    "researchanddevelopmentexpense": 18693000,
    "generalandadministrativeexpense": 7104000,
    "operatingexpenses": 25797000,
    "operatingincomeloss": -25797000,
    "othernonoperatingincomeexpense": -5263000,
    "netincomeloss": -31060000,
    "comprehensiveincomenetoftax": -31060000,
    "earningspersharebasic": -1.69,
    "weightedaveragenumberofsharesoutstandinginshares": 18394886,
    "earningspersharediluted": -1.69,
    "sharesoutstanding": 18421852,
    "stockissuedduringperiodvaluestockoptionsexercisednetoftaxbenefitexpense": 150000,
    "stockissuedduringperiodsharesstockoptionsexercised": 22875,
    "stockissuedduringperiodvaluerestrictedstockawardgross": -7000,
    "stockissuedduringperiodsharesrestrictedstockawardgross": 67470,
    "adjustmentstoadditionalpaidincapitalsharebasedcompensationrequisiteserviceperiodrecognitionvalue": 2712000,
    "depreciation": 777000,
    "marketablesecuritiesunrealizedgainloss": -1983000,
    "noncashoperatingleaseexpense": 831000,
    "sharebasedcompensation": 1836000,
    "increasedecreaseinprepaiddeferredexpenseandotherassets": -278000,
    "increasedecreaseinaccountspayablestrade": 1168000,
    "increasedecreaseinaccruedliabilitiesandotheroperatingliabilities": 684000,
    "increasedecreaseinoperatingliabilities": -1326000,
    "netcashprovidedbyusedinoperatingactivities": -23953000,
    "paymentstoacquirepropertyplantandequipment": 8122000,
    "investmentinshorttermbankdeposits": 9705000,
    "paymentstoacquiremarketablesecurities": 1608000,
    "proceedsfromsaleandmaturityofmarketablesecurities": 62549000,
    "netcashprovidedbyusedininvestingactivities": 62524000,
    "proceedsfromstockoptionsexercised": 150000,
    "netcashprovidedbyusedinfinancingactivities": 150000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseexcludingexchangerateeffect": 38721000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalents": 50357000,
    "cashreceivedforinterestnet": 666000,
    "prepaidexpensesandotherreceivablestextblock": "NOTE 5 – PREPAID EXPENSES AND OTHER RECEIVABLES",
    "leasesoflesseedisclosurestextblock": "NOTE 9– LEASES  ",
    "marketablesecuritiespolicytextblock": "Marketable securities ",
    "preclinicalandclinicaltrialaccrualspolicytextblock": "Preclinical and clinical trialaccruals ",
    "patentspolicytextblock": "Patents ",
    "propertyplantandequipmentestimatedusefullivesdepreciationratestabletextblock": "            %       Computers       33.33       Office furniture and equipment       7       Leasehold improvements       16.67       Laboratory equipment       15-30     ",
    "descriptionofdifferencebetweenreportedamountandreportingcurrencydenominatedamount": "NIS 3.519",
    "increasedecreaseduringtheyears": 0.1315,
    "propertyplantandequipmentstraightlinepercentage": 0.3,
    "incomelossfromcontinuingoperations": 31060000,
    "netincomelossavailabletocommonstockholdersbasic": 31060000,
    "numberofcommonshares": 18331507,
    "weightedaveragenumberofstockoptionsexercisedinshares": 13015,
    "weightedaveragenumberofrestrictedstockunitsvested": 50364,
    "numberofsharesusedinpersharecomputation": 18394886,
    "basicanddilutednetlosspershareindollarspershare": -1.69,
    "cashandduefrombanks": 2123000,
    "deposits": 47822000,
    "prepaidexpenseandotherassets": 113000,
    "regulatedentityotherassetsnoncurrent": 299000,
    "restrictedcashandcashequivalents": 50357000,
    "annualaverageinterestrates": 0.0395,
    "shorttermdebtinterestrateincrease": 0.003,
    "prepaidexpensecurrentandnoncurrent": 1439000,
    "unrecognizedtaxbenefitsincometaxpenaltiesandinterestexpense": 522000,
    "otherprepaidexpensecurrent": 125000,
    "prepaidexpensecurrent": 2086000,
    "propertyplantandequipmentgross": 11982000,
    "accumulateddepreciationdepletionandamortizationpropertyplantandequipment": 2107000,
    "restrictedcashcurrent": 299000,
    "depositassets": 8000,
    "longtermprepaidexpense": 105000,
    "rightofuseassetsnet": 5025000,
    "vacationconvalescenceandbonusaccruals": 759000,
    "employeerelatedliabilitiescurrent": 1289000,
    "shorttermoperatingleaseliabilities": -653000,
    "otheraccruedliabilitiescurrent": 2708000,
    "operatingleaseexpense": 1037000,
    "cashusedinoperatingactivities": 875000,
    "rightofuseassetsobtainedinexchangefornewoperatingleaseliabilities": 179000,
    "otherassetsrightofuseassets": 6445000,
    "accumulatedamortization": 1420000,
    "operatingleaserightofuseassetsnet": 5025000,
    "accountspayableandaccruedliabilities": 653000,
    "leaseliabilitiesnoncurrent": 4194000,
    "totaloperatingleaseliabilities": 4847000,
    "operatingleaseweightedaverageremainingleaseterm1": 7.6,
    "operatingleaseweightedaveragediscountratepercent": 0.034,
    "lesseeoperatingleaseliabilitypaymentsduenexttwelvemonths": 788000,
    "lesseeoperatingleaseliabilitypaymentsdueyeartwo": 681000,
    "lesseeoperatingleaseliabilitypaymentsdueyearthree": 703000,
    "lesseeoperatingleaseliabilitypaymentsdueyearfour": 607000,
    "lesseeoperatingleaseliabilitypaymentsdueafteryearfive": 2752000,
    "lesseeoperatingleaseliabilityundiscountedexcessamount": 5531000,
    "lessimputedinterest": 684000,
    "lesseeoperatingleaseliabilitypaymentsdue": 4847000,
    "classofwarrantorrightnumberofsecuritiescalledbywarrantsorrights": 704355,
    "weightedaverageexercisespriceoutstanding": 23.31,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 5.49,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresandexpirationsinperiod": 40730,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsforfeituresinperiodweightedaverageexerciseprice": 9.09,
    "classofwarrantorrightoutstanding": 202251,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 5.85,
    "numberofwarrantsoutstanding": 202251,
    "remainingcontractuallifeinyears": 3.11,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrate": 0.034100000000000005,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrate": 0.9162,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": 5,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": 2939434,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodgross": 860492,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresandexpirationsinperiodweightedaverageexerciseprice": 6.42,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexercisesinperiodweightedaverageexerciseprice": 6.49,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisablenumber": 1953429,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageexerciseprice": 5.55,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsnonvestednumberofshares": 986005,
    "weightedaverageexerciseprices": 10.02,
    "sharebasedcompensationsarrangementbysharebasedpaymentawardoptionsgrantednumberofshares": 860492,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 5.49,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestednumberofshares": 67458,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedinperiodweightedaverageexerciseprice": 9.91,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsnonvestedoptionsforfeitednumberofshares": 4313,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeitedinperiodweightedaverageexerciseprice": 14.67,
    "exercisepriceindollarspershare": 90.16,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm2": 1.92,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingaggregateintrinsicvalue": 880000,
    "numberofsharesnonvestedatbeginningofperiodinpershare": 229331,
    "weightedaveragegrantdatefairvaluenonvestedatbeginningofperiod": 10.08,
    "numberofsharesnonvestedatend": 157560,
    "effectiveincometaxratereconciliationatfederalstatutoryincometaxrate": 0.23,
    "effectiveincometaxratereconciliationforeignincometaxratedifferential": -0.04,
    "effectiveincometaxratereconciliationchangeindeferredtaxassetsvaluationallowance": -0.19,
    "deferredtaxassetstaxdeferredexpensecompensationandbenefitsemployeebenefits": 213000,
    "deferredtaxassetstaxdeferredexpensecompensationandbenefitssharebasedcompensationcost": 1365000,
    "deferredtaxassetsinprocessresearchanddevelopment": 3486000,
    "deferredtaxassetsfixedassets": 185000,
    "deferredtaxassetsoperatinglosscarryforwards": 23693000,
    "deferredtaxassetsgross": 28942000,
    "deferredtaxassetsvaluationallowance": 28942000,
    "cashandcashequivalentsfairvaluedisclosure": 49945000,
    "investmentsfairvaluedisclosure": 299000,
    "otherassetsfairvaluedisclosure": 412000,
    "assetsfairvaluedisclosure": 50656000,
    "accruedpayrolltaxescurrent": 6371000,
    "researchanddevelopmentinprocess": 8264000,
    "inventoryrawmaterials": 2044000,
    "sharebasedcompensations": 876000,
    "depreciations": 740000,
    "other": 1605000,
    "researchanddevelopmentexpensesgross": 19900000,
    "israelinnovationauthorityparticipationinresearchanddevelopmentcostsandroyaltiespayable": 1207000,
    "researchanddevelopmentexpensesoftwareexcludingacquiredinprocesscost": 18693000,
    "incometaxreconciliationnondeductibleexpensesharebasedcompensationcost": 681000,
    "accruedprofessionalfeescurrent": 1294000,
    "utilitiesoperatingexpensemaintenanceandoperations": 402000,
    "prepaidinsurance": 895000,
    "stockissuedduringperiodvalueemployeebenefitplan": 1836000,
    "otherexpenses": 707000,
    "investmentincomeinterest": 835000,
    "othercomprehensiveincomeunrealizedholdinggainlossonsecuritiesarisingduringperiodnetoftax": -1983000,
    "deferredtaxassetsotherlosscarryforwards": 4101000,
    "bankcommissionsandotherexpenses": 14000,
    "financialexpenses": -5263000,
    "sharesissuedpricepershare": 0.4,
    "accumulateddeficit": 83200000,
    "netlossgainrecognizedonequitysecurities": -1983000,
    "patentsrelatedcosts": 536000,
    "taxbenefitpercentage": 0.5,
    "deferredincometaxliabilities": 705000,
    "weightedaveragenumberofsharesrelatedtooutstandingpotentialsharesexcludedfromthecalculationsofdilutednetlosspershare": 2902423,
    "leaseagreementsperiod": 36,
    "royaltiesinsalespercentage": 1,
    "businesscombinationrecognizedidentifiableassetsacquiredandliabilitiesassumedcontingentliability": 9200000,
    "partnerscapitalaccountpublicsaleofunitsnetofofferingcosts": 137,
    "stockissuedduringperiodsharesnewissues": 4150704,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnumberofsharesavailableforgrant": 635594,
    "expiregrantyear": "ten years",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 5.49,
    "sharebasedcompensationarrangementbysharebasedpaymentawardcompensationcost1": 2746,
    "allocatedsharebasedcompensationexpense": 744000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognized": 516000,
    "weightedaverageperiod": 1.16,
    "israelicorporatetaxrate": 0.23,
    "operatinglosscarryforwards": 500000,
    "otherresearchanddevelopmentexpense": 1322000,
    "accruedsalariescurrentandnoncurrent": 410000,
    "entityregistrantname": "Enlivex Therapeutics Ltd.",
    "tradingsymbol": "ENLV",
    "documenttype": "20-F",
    "currentfiscalyearenddate": "December 31",
    "entitycommonstocksharesoutstanding": 18421852,
    "amendmentflag": "false",
    "entitycentralindexkey": 1596812,
    "entitycurrentreportingstatus": "Yes",
    "entityvoluntaryfilers": "No",
    "entityfilercategory": "Accelerated filer",
    "entitywellknownseasonedissuer": "No",
    "documentperiodenddate": "December 31, 2022",
    "documentfiscalyearfocus": 2022,
    "documentfiscalperiodfocus": "FY",
    "entityemerginggrowthcompany": "false",
    "entityshellcompany": "true",
    "icfrauditorattestationflag": "true",
    "documentregistrationstatement": "false",
    "documentannualreport": "true",
    "documenttransitionreport": "false",
    "documentshellcompanyreport": "false",
    "entityfilenumber": "001-36578",
    "entityincorporationstatecountrycode": "Israel",
    "entityaddressaddressline1": "14 Einstein Street",
    "entityaddresscityortown": "Ness Ziona",
    "entityaddresscountry": "Israel",
    "entityaddresspostalzipcode": 7403618,
    "contactpersonnelname": "Mr. Oren Hershkovitz",
    "cityareacode": 972,
    "localphonenumber": 2.6208072,
    "contactpersonnelemailaddress": "Oren@enlivexpharm.com",
    "contactpersonnelfaxnumber": "+972.2.6208070",
    "security12btitle": "Ordinary Shares, par value of NIS 0.40",
    "securityexchangename": "Nasdaq",
    "entityinteractivedatacurrent": "Yes",
    "documentaccountingstandard": "U.S. GAAP",
    "auditorfirmid": 1024,
    "auditorname": "Yarel + Partners",
    "auditorlocation": "Tel-Aviv, Israel"
  },
  {
    "date": "2021-12-31",
    "symbol": "ENLV",
    "period": "FY",
    "cashandcashequivalentsatcarryingvalue": 11202000,
    "depositsassetscurrent": 10004000,
    "marketablesecuritiescurrent": 62924000,
    "prepaidexpenseandotherassetscurrent": 2199000,
    "receivablesheldforsaleamount": 113000,
    "assetscurrent": 86442000,
    "propertyplantandequipmentnet": 2530000,
    "otherassets": 6174000,
    "assetsnoncurrent": 8704000,
    "assets": 95146000,
    "accountspayabletradecurrent": 275000,
    "accountspayableandotheraccruedliabilitiescurrent": 115000,
    "cvrholders": 113000,
    "liabilitiescurrent": 4718000,
    "otherlongtermdebt": 5389000,
    "liabilitiesnoncurrent": 5389000,
    "liabilities": 10107000,
    "commonstockvalue": 2107000,
    "additionalpaidincapital": 133796000,
    "accumulatedothercomprehensiveincomelossforeigncurrencytranslationadjustmentnetoftax": 1101000,
    "retainedearningsaccumulateddeficit": -51965000,
    "stockholdersequity": -51965000,
    "liabilitiesandstockholdersequity": 95146000,
    "commonstockparorstatedvaluepershare": 0.4,
    "commonstocksharesauthorized": 45000000,
    "commonstocksharesissued": 18331507,
    "commonstocksharesoutstanding": 18331507,
    "researchanddevelopmentexpense": 12881000,
    "generalandadministrativeexpense": 6407000,
    "operatingexpenses": 19288000,
    "operatingincomeloss": -19288000,
    "othernonoperatingincomeexpense": 4820000,
    "netincomeloss": -14468000,
    "othercomprehensiveincomeforeigncurrencytransactionandtranslationadjustmentnetoftaxportionattributabletoparent": 124000,
    "othercomprehensiveincomelossnetoftaxportionattributabletoparent": 124000,
    "comprehensiveincomenetoftax": -14344000,
    "basicdilutedlosspershareindollarspershare": -0.81,
    "weightedaveragenumberofsharesoutstandinginshares": 17859713,
    "sharesoutstanding": 18331507,
    "issuanceofsharesandwarrantsforcashconsiderationofissuancecosts": 53174000,
    "stockissuedduringperiodsharesother": 2848629,
    "stockissuedduringperiodvaluestockoptionsexercised": 106000,
    "stockissuedduringperiodsharesstockoptionsexercised": 39131,
    "exerciseofwarrants": 7702000,
    "exerciseofwarrantsshares": 855813,
    "adjustmentstoadditionalpaidincapitalsharebasedcompensationrequisiteserviceperiodrecognitionvalue": 2914000,
    "othercomprehensivegain": 124000,
    "cashconsideration": 57629000,
    "proceedsfromdebtnetofissuancecosts": 4455000,
    "depreciation": 546000,
    "marketablesecuritiesunrealizedgainloss": 5590000,
    "noncashoperatingleaseexpense": 413000,
    "sharebasedcompensation": 1704000,
    "increasedecreaseinprepaiddeferredexpenseandotherassets": 1249000,
    "increasedecreaseinaccountspayablestrade": 442000,
    "increasedecreaseinaccruedliabilitiesandotheroperatingliabilities": -466000,
    "increasedecreaseinoperatingliabilities": -84000,
    "netcashprovidedbyusedinoperatingactivities": -17542000,
    "paymentstoacquirepropertyplantandequipment": 1625000,
    "investmentinshorttermbankdeposits": 20030000,
    "paymentstoacquiremarketablesecurities": 104417000,
    "proceedsfromsaleandmaturityofmarketablesecurities": 47604000,
    "netcashprovidedbyusedininvestingactivities": -38408000,
    "proceedsfromissuanceofpreferredstockpreferencestockandwarrants": 53174000,
    "proceedsfromwarrantexercises": 7702000,
    "proceedsfromstockoptionsexercised": 106000,
    "netcashprovidedbyusedinfinancingactivities": 60982000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseexcludingexchangerateeffect": 5032000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalents": 11636000,
    "effectofexchangerateoncashcashequivalentsrestrictedcashandrestrictedcashequivalents": -408000,
    "cashreceivedforinterestnet": 39000,
    "reversemergerwithbioblastpharmadisclosuretextblock": "NOTE 8 – REVERSE MERGER WITH BIOBLAST PHARMA LTD. ",
    "leasesoflesseedisclosurestextblock": "NOTE 9 – LEASES  ",
    "marketablesecuritiespolicytextblock": "Marketable Securities.  ",
    "preclinicalandclinicaltrialaccrualspolicytextblock": "Preclinical and Clinical TrialAccruals ",
    "patentspolicytextblock": "Patents ",
    "recentlyadoptedaccountingstandardspolicytextblock": "Recently Issued Accounting Standards ",
    "propertyplantandequipmentestimatedusefullivesdepreciationratestabletextblock": "            %       Computers      33       Office furniture and equipment      7       Leasehold improvements      16.67       Laboratory equipment      15-30    ",
    "descriptionofdifferencebetweenreportedamountandreportingcurrencydenominatedamount": "NIS 3.110",
    "increasedecreaseduringtheyears": -0.033,
    "averageyearlyexchangerate": "NIS 3.2302",
    "propertyplantandequipmentstraightlinepercentage": 0.3,
    "incomelossfromcontinuingoperations": 14468000,
    "netincomelossavailabletocommonstockholdersbasic": 14468000,
    "numberofcommonshares": 14587934,
    "weightedaveragenumberofsharesissuedforcash": 2485245,
    "weightedaveragenumberofstockoptionsexercisedinshares": 16715,
    "weightedaveragenumberofwarrantsexercised": 769819,
    "numberofsharesusedinpersharecomputation": 17859713,
    "basicanddilutednetlosspershareindollarspershare": -0.81,
    "interesttocummulativepreferredstock": 0.06,
    "cashandduefrombanks": 1199000,
    "deposits": 3000,
    "cashheldwithrespecttocvragreement": 113000,
    "regulatedentityotherassetsnoncurrent": 321000,
    "restrictedcashandcashequivalents": 11636000,
    "annualaverageinterestrates": 0.001,
    "shorttermdebtinterestrateincrease": 0.006,
    "propertyplantandequipmentgross": 3860000,
    "accumulateddepreciationdepletionandamortizationpropertyplantandequipment": 1330000,
    "restrictedcash": 321000,
    "longtermprepaidexpense": 161000,
    "operatingleaserightofuseasset": 5689000,
    "vacationconvalescenceandbonusaccruals": 1068000,
    "employeerelatedliabilitiescurrent": 1138000,
    "shorttermoperatingleaseliabilities": 617000,
    "otheraccruedliabilitiescurrent": 1523000,
    "cashequivalentsatcarryingvalue": 44000,
    "prepaidexpensesandotherreceivable": 632000,
    "assetsheldintrustcurrent": 1500000,
    "receivablesforthesaleoftrehalose": 2000000,
    "tradepayablescurrent": 10000,
    "duetorelatedpartiescurrent": 3500000,
    "otherliabilitiescurrent": 22000,
    "assetsliabilityatfairvaluenet": 644000,
    "operatingleaseexpense": 698000,
    "cashusedinoperatingactivities": 449000,
    "rightofuseassetsobtainedinexchangefornewoperatingleaseliabilities": 5446000,
    "otherassetsrightofuseassets": 6329000,
    "accumulatedamortization": 640000,
    "operatingleaserightofuseassetsnet": 5689000,
    "accountspayableandaccruedliabilities": 617000,
    "leaseliabilitiesnoncurrent": 5389000,
    "totaloperatingleaseliabilities": 6006000,
    "operatingleaseweightedaverageremainingleaseterm1": 8.6,
    "operatingleaseweightedaveragediscountratepercent": 0.036000000000000004,
    "lesseeoperatingleaseliabilitypaymentsdueyearthree": 823000,
    "lesseeoperatingleaseliabilitypaymentsdueyearfour": 833000,
    "lesseeoperatingleaseliabilitypaymentsdueyearfive": 711000,
    "lesseeoperatingleaseliabilitypaymentsdueafteryearfive": 776000,
    "finitelivedintangibleassetsamortizationexpenserollingafteryearfive": 3830000,
    "totalundiscountedleaseliability": 6973000,
    "lessimputedinterest": -967000,
    "presentvalueofleaseliabilities": 6006000,
    "classofwarrantorrightnumberofsecuritiescalledbywarrantsorrights": 1407683,
    "weightedaverageexercisespriceoutstanding": 13.18,
    "numberofwarrantsissued": 179501,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 12.14,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresandexpirationsinperiod": 48242,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsforfeituresinperiodweightedaverageexerciseprice": 180,
    "classofwarrantorrightexercisepriceofwarrantsorrights1": 9,
    "classofwarrantorrightoutstanding": 704355,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 6.02,
    "numberofwarrantsoutstanding": 704355,
    "remainingcontractuallifeinyears": 4.11,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrate": 0.008199999999999999,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrate": 0.9157,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": 5,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": 2142547,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodgross": 236706,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresandexpirationsinperiodweightedaverageexerciseprice": 33.11,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexercisesinperiodweightedaverageexerciseprice": 2.89,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisablenumber": 1613465,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageexerciseprice": 4.9,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsnonvestednumberofshares": 529082,
    "weightedaverageexerciseprices": 10.08,
    "sharebasedcompensationsarrangementbysharebasedpaymentawardoptionsgrantednumberofshares": 345500,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 10.22,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestednumberofshares": 385798,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedinperiodweightedaverageexerciseprice": 7.39,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsnonvestedoptionsforfeitednumberofshares": 7375,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeitedinperiodweightedaverageexerciseprice": 14.67,
    "exercisepriceindollarspershare": 90.16,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm2": 1.46,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingaggregateintrinsicvalue": 3066494000,
    "numberofsharesnonvestedatend": 229331,
    "incomelossfromcontinuingoperationsbeforeincometaxesextraordinaryitemsnoncontrollinginterest": 14468000,
    "effectiveincometaxratereconciliationatfederalstatutoryincometaxrate": 0.23,
    "othertaxexpensebenefit": 3328000,
    "incometaxreconciliationpermanentdifferences": 975000,
    "incometaxreconciliationchangeindeferredtaxassetsvaluationallowance": -4303000,
    "deferredtaxassetstaxdeferredexpensecompensationandbenefitsemployeebenefits": 308000,
    "deferredtaxassetstaxdeferredexpensecompensationandbenefitssharebasedcompensationcost": 746000,
    "deferredtaxassetsinprocessresearchanddevelopment": 2527000,
    "deferredtaxassetsoperatinglosscarryforwards": 22444000,
    "deferredtaxassetsgross": 26025000,
    "deferredtaxassetsvaluationallowance": 26025000,
    "cashandcashequivalentsfairvaluedisclosure": 11202000,
    "investmentsfairvaluedisclosure": 10004000,
    "cashheldwithrespectstocvragreement": 113000,
    "marketablesecurities": 62924000,
    "otherassetsfairvaluedisclosure": 321000,
    "assetsfairvaluedisclosure": 84564000,
    "accruedpayrolltaxescurrent": 5054000,
    "researchanddevelopmentinprocess": 4557000,
    "inventoryrawmaterials": 1505000,
    "sharebasedcompensations": 1210000,
    "depreciations": 546000,
    "other": 1029000,
    "researchanddevelopmentexpensesgross": 13901000,
    "researchanddevelopmentassetacquiredotherthanthroughbusinesscombinationwrittenoff": 1020000,
    "researchanddevelopmentexpensesoftwareexcludingacquiredinprocesscost": 12881000,
    "incometaxreconciliationnondeductibleexpensesharebasedcompensationcost": 1168000,
    "accruedprofessionalfeescurrent": 1080000,
    "utilitiesoperatingexpensemaintenanceandoperations": 167000,
    "prepaidinsurance": 783000,
    "stockissuedduringperiodvalueemployeebenefitplan": 1704000,
    "otherexpenses": 367000,
    "investmentincomeinterest": 120000,
    "othercomprehensiveincomeunrealizedholdinggainlossonsecuritiesarisingduringperiodnetoftax": 5590000,
    "deferredtaxassetsotherlosscarryforwards": 562000,
    "bankcommissionsandotherexpenses": 328000,
    "financialexpenses": 4820000,
    "accumulateddeficit": 52000000,
    "amountraisedinconjunctionwithsecuritiesofferings": 53200000,
    "additionalamountraisedfromexercisesofoptionsandwarrants": 7800000,
    "netgainrecognizedonequitysecuritie": 5590,
    "netgainonequitysecuritiesnotrealized": 4599,
    "patentsrelatedcosts": 373,
    "taxbenefitpercentage": 0.5,
    "deferredincometaxliabilities": 705,
    "weightedaveragenumberofsharesrelatedtooutstandingpotentialsharesexcludedfromthecalculationsofdilutednetlosspershare": 2910491,
    "estimatedfairvalueoftotalconsiderations": 5152000,
    "adjustedpermergeragreement": 420554,
    "sharepricepershare": 12.25,
    "fairvaluenetassetliability": 4508000,
    "lesseeoperatingleaseremainingleaseterm": 22,
    "leaseagreementsperiod": 36,
    "royaltiesinsalespercentage": 1,
    "businesscombinationrecognizedidentifiableassetsacquiredandliabilitiesassumedcontingentliability": 7800000,
    "granttotalamount": 1200000,
    "salesagentcommissionpercentage": 0.07,
    "grossproceedsinpercentage": 0.01,
    "warrantstopurchase": 179501,
    "costsandexpenses": 126000,
    "partnerscapitalaccountpublicsaleofunitsnetofofferingcosts": 47023000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 6.23,
    "sharebasedcompensationarrangementbysharebasedpaymentawardcompensationcost1": 1905,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisesinperiodtotalintrinsicvalue": 336000,
    "allocatedsharebasedcompensationexpense": 1024000,
    "israelicorporatetaxrate": 0.23,
    "operatinglosscarryforwards": 41000000,
    "otherresearchanddevelopmentexpense": 1331000,
    "entityregistrantname": "Enlivex Therapeutics Ltd.",
    "tradingsymbol": "ENLV",
    "documenttype": "20-F",
    "currentfiscalyearenddate": "December 31",
    "entitycommonstocksharesoutstanding": 18331507,
    "amendmentflag": "false",
    "entitycentralindexkey": 1596812,
    "entitycurrentreportingstatus": "Yes",
    "entityvoluntaryfilers": "No",
    "entityfilercategory": "Accelerated filer",
    "entitywellknownseasonedissuer": "No",
    "documentperiodenddate": "December 31, 2021",
    "documentfiscalyearfocus": 2021,
    "documentfiscalperiodfocus": "FY",
    "entityemerginggrowthcompany": "false",
    "entityshellcompany": "true",
    "icfrauditorattestationflag": "true",
    "documentregistrationstatement": "false",
    "documentannualreport": "true",
    "documenttransitionreport": "false",
    "documentshellcompanyreport": "false",
    "entityfilenumber": "001-36578",
    "entityincorporationstatecountrycode": "Israel",
    "entityaddressaddressline1": "14 Einstein Street",
    "entityaddresscityortown": "Nes Ziona",
    "entityaddresscountry": "Israel",
    "entityaddresspostalzipcode": 7403618,
    "contactpersonnelname": "Mr. Oren Hershkovitz",
    "cityareacode": 972,
    "localphonenumber": 2.6208072,
    "contactpersonnelemailaddress": "Oren@enlivexpharm.com",
    "contactpersonnelfaxnumber": "+972.2.6208070",
    "security12btitle": "Ordinary Shares, par value of NIS 0.40",
    "securityexchangename": "Nasdaq",
    "entityinteractivedatacurrent": "Yes",
    "documentaccountingstandard": "U.S. GAAP",
    "auditorfirmid": 1024,
    "auditorname": "Yarel + Partners",
    "auditorlocation": "Tel-Aviv, Israel"
  },
  {
    "date": "2020-12-31",
    "symbol": "ENLV",
    "period": "FY",
    "cashandcashequivalentsatcarryingvalue": 5673000,
    "depositsassetscurrent": 30034000,
    "prepaidexpenseandotherassetscurrent": 1164000,
    "restrictedcashcurrent": 79000,
    "cashheldwithrespecttocvragreement": 1171000,
    "assetscurrent": 38121000,
    "propertyplantandequipmentnet": 1481000,
    "otherassets": 756000,
    "assetsnoncurrent": 2237000,
    "assets": 40358000,
    "accountspayabletradecurrent": 463000,
    "accountspayableandotheraccruedliabilitiescurrent": 2738000,
    "cvrholders": 1171000,
    "liabilitiescurrent": 4372000,
    "otherlongtermdebt": 499000,
    "liabilitiesnoncurrent": 499000,
    "liabilities": 4871000,
    "commonstockvalue": 1646000,
    "additionalpaidincapital": 70361000,
    "accumulatedothercomprehensiveincomelossforeigncurrencytranslationadjustmentnetoftax": 977000,
    "retainedearningsaccumulateddeficit": -37497000,
    "stockholdersequity": 35487000,
    "liabilitiesandstockholdersequity": 40358000,
    "commonstockparorstatedvaluepershare": 0.4,
    "commonstocksharesauthorized": 45000000,
    "commonstocksharesissued": 14587934,
    "commonstocksharesoutstanding": 14587934,
    "researchanddevelopmentexpense": 6086000,
    "generalandadministrativeexpense": 3699000,
    "operatingexpenses": 9785000,
    "operatingincomeloss": -9785000,
    "othernonoperatingincome": 225000,
    "othernonoperatingexpense": 2264000,
    "netincomeloss": -11824000,
    "othercomprehensiveincomeforeigncurrencytransactionandtranslationadjustmentnetoftaxportionattributabletoparent": 2277000,
    "othercomprehensiveincomelossnetoftaxportionattributabletoparent": 2277000,
    "comprehensiveincomenetoftax": -9547000,
    "earningspersharebasicanddiluted": -0.9,
    "weightedaveragenumberofshareoutstandingbasicanddiluted": 13169208,
    "sharesoutstanding": 14587934,
    "sharesandwarrantsissuedduringperiodissuanceofcashconsiderationofstockvalues": 382000,
    "sharesandwarrantsissuedduringperiodissuanceofcashconsiderationofstockshares": 3286416,
    "stockissuedduringperiodvaluestockoptionsexercised": 4000,
    "stockissuedduringperiodsharesstockoptionsexercised": 37746,
    "exerciseofwarrants": 109000,
    "exerciseofwarrantsshares": 929646,
    "adjustmentstoadditionalpaidincapitalsharebasedcompensationrequisiteserviceperiodrecognitionvalue": 670000,
    "cashconsideration": 26968000,
    "proceedsfromdebtnetofissuancecosts": 2501000,
    "depreciation": 286000,
    "noncashoperatingleaseexpense": 167000,
    "sharebasedcompensation": 670000,
    "increasedecreaseinprepaiddeferredexpenseandotherassets": -1823000,
    "increasedecreaseinaccountspayablestrade": 36000,
    "increasedecreaseinaccruedliabilitiesandotheroperatingliabilities": -2022000,
    "increasedecreaseinoperatingliabilities": -143000,
    "netcashprovidedbyusedinoperatingactivities": -11007000,
    "paymentstoacquirepropertyplantandequipment": 1019000,
    "investmentinshorttermbankdeposits": -19958000,
    "netcashprovidedbyusedininvestingactivities": -20977000,
    "proceedsfromissuanceofpreferredstockpreferencestockandwarrants": 24467000,
    "proceedsfromwarrantexercises": 8514000,
    "proceedsfromstockoptionsexercised": 101000,
    "netcashprovidedbyusedinfinancingactivities": 33082000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseexcludingexchangerateeffect": 1098000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalents": 7012000,
    "effectofexchangerateoncashandcashequivalents": 390000,
    "warrantsissuedinsettlementofissuancecoststoplacementagent": 564000,
    "interestreceivednet": 160000,
    "descriptionofdifferencebetweenreportedamountandreportingcurrencydenominatedamount": "NIS 3.215",
    "increasedecreaseduringtheyears": -0.07,
    "averageyearlyexchangerate": "NIS 3.442",
    "propertyplantandequipmentstraightlinepercentage": 0.33,
    "incomelossfromcontinuingoperations": -11824000,
    "netincomelossavailabletocommonstockholdersbasic": -11824000,
    "numberofcommonshares": 10334126,
    "weightedaveragenumberofsharesissuedforcash": 2603763,
    "weightedaveragenumberofstockoptionsexercisedinshares": 21749,
    "weightedaveragenumberofwarrantsexercised": 209570,
    "numberofsharesusedinpersharecomputation": 13169208,
    "interesttocummulativepreferredstock": 0.06,
    "cashandduefrombanks": 1173000,
    "deposits": 4500000,
    "shorttermrestrictedcash": 79000,
    "longtermrestrictedbankdeposits": 89000,
    "annualaverageinterestrates": 0.0032,
    "shorttermdebtinterestrateincrease": 0.006,
    "propertyplantandequipmentgross": 1256000,
    "accumulateddepreciationdepletionandamortizationpropertyplantandequipment": 588000,
    "restrictedcash": 89000,
    "longtermprepaidexpense": 8000,
    "operatingleaserightofuseasset": 659000,
    "vacationconvalescenceandbonusaccruals": 684000,
    "employeerelatedliabilitiescurrent": 352000,
    "shorttermoperatingleaseliabilities": 203000,
    "otheraccruedliabilitiescurrent": 1499000,
    "cashequivalentsatcarryingvalue": 44000,
    "prepaidexpensesandotherreceivable": 632000,
    "assetsheldintrustcurrent": 1500000,
    "receivablesforthesaleoftrehalose": 2000000,
    "tradepayablescurrent": 10000,
    "duetorelatedpartiescurrent": 3500000,
    "otherliabilitiescurrent": 22000,
    "assetsliabilityatfairvaluenet": 644000,
    "operatingleaseexpense": 243000,
    "cashusedinoperatingactivities": 223000,
    "rightofuseassetsobtainedinexchangefornewoperatingleaseliabilities": 398000,
    "otherassetsrightofuseassets": 920000,
    "accumulatedamortization": 261000,
    "operatingleaserightofuseassetsnet": 659000,
    "accountspayableandaccruedliabilities": 203000,
    "leaseliabilitiesnoncurrent": 499000,
    "totaloperatingleaseliabilities": 702000,
    "operatingleaseweightedaverageremainingleaseterm1": "P3Y7M20D",
    "operatingleaseweightedaveragediscountratepercent": 0.119,
    "lesseeoperatingleaseliabilitypaymentsdueyeartwo": 258000,
    "lesseeoperatingleaseliabilitypaymentsdueyearthree": 231000,
    "lesseeoperatingleaseliabilitypaymentsdueyearfour": 182000,
    "lesseeoperatingleaseliabilitypaymentsdueyearfive": 93000,
    "lesseeoperatingleaseliabilitypaymentsdueafteryearfive": 53000,
    "operatingleasesfutureminimumpaymentsdue": 817000,
    "lessimputedinterest": -115000,
    "presentvalueofleaseliabilities": 702000,
    "classofwarrantorrightnumberofsecuritiescalledbywarrantsorrights": 146563,
    "classofwarrantorrightexercisepriceofwarrantsorrights1": 10,
    "warrantsandrightsissuancedate": "2016-03-22",
    "warrantsandrightsoutstandingmaturitydate": "2021-09-22",
    "classofwarrantorrightoutstanding": 1407683,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrate": 0.0067,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrate": 0.7632,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": "P2Y",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": 1884420,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 5.52,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodgross": 360500,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 4.46,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresandexpirationsinperiod": 63376,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresandexpirationsinperiodweightedaverageexerciseprice": 6.26,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexercisesinperiodweightedaverageexerciseprice": 2.69,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisablenumber": 1283193,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageexerciseprice": 5.15,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsnonvestednumberofshares": 601227,
    "weightedaverageexerciseprices": 5.93,
    "sharebasedcompensationsarrangementbysharebasedpaymentawardoptionsgrantednumberofshares": 360500,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 3.86,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestednumberofshares": 249965,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedinperiodweightedaverageexerciseprice": 6.07,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsnonvestedoptionsforfeitednumberofshares": 35659,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeitedinperiodweightedaverageexerciseprice": 6.24,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm2": "P2Y",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingaggregateintrinsicvalue": 3937594000,
    "incomelossfromcontinuingoperationsbeforeincometaxesminorityinterestandincomelossfromequitymethodinvestments": 11824000,
    "effectiveincometaxratereconciliationatfederalstatutoryincometaxrate": 0.23,
    "othertaxexpensebenefit": 2720000,
    "incometaxreconciliationpermanentdifferences": 642000,
    "incometaxreconciliationchangeindeferredtaxassetsvaluationallowance": -3362000,
    "deferredtaxassetstaxdeferredexpensecompensationandbenefitsemployeebenefits": 61000,
    "deferredtaxassetsinprocessresearchanddevelopment": 1275000,
    "deferredtaxassetsoperatinglosscarryforwards": 8303000,
    "deferredtaxassetsgross": 9639000,
    "deferredtaxassetsvaluationallowance": 9639000,
    "accountspayablerelatedpartiescurrent": 175000,
    "cashandcashequivalentsfairvaluedisclosure": 5673000,
    "investmentsfairvaluedisclosure": 30034000,
    "cashheldwithrespectstocvragreement": 1171000,
    "otherassetsfairvaluedisclosure": 168000,
    "assetsfairvaluedisclosure": 37046000,
    "researchanddevelopmentexpensespayrollandrelatedexpenses": 3183000,
    "researchanddevelopmentservices": 2438000,
    "materials": 612000,
    "researchanddevelopmentexpensessharebasedcompensation": 401000,
    "researchanddevelopmentexpensesdepreciation": 273000,
    "researchanddevelopmentexpensesother": 394000,
    "researchanddevelopmentexpensesgross": 7301000,
    "researchanddevelopmentassetacquiredotherthanthroughbusinesscombinationwrittenoff": 1215000,
    "researchanddevelopmentexpenses": 6086000,
    "laborandrelatedexpense": 737000,
    "compensationtodirectors": 862000,
    "generalandadministrativeexpensesprofessionalfees": 995000,
    "othergeneralandadministrativeexpense": 97000,
    "insuranceexpense": 486000,
    "generalandadministrativeexpensessharebasedcompensation": 269000,
    "otherexpenses": 253000,
    "interestincomeother": 225000,
    "foreigncurrencytransactionlossbeforetax": 2258000,
    "bankcommissions": 6000,
    "amountraisedinconjunctionwithsecuritiesofferings": 29500000,
    "additionalamountraisedfromexercisesofoptionsandwarrants": 8600000,
    "patentsrelatedcosts": 374000,
    "taxbenefitpercentage": 0.5,
    "deferredincometaxliabilities": 682000,
    "weightedaveragenumberofsharesrelatedtooutstandingpotentialshares": 3526214,
    "estimatedfairvalueoftotalconsiderations": 5152000,
    "adjustedpermergeragreement": 420554,
    "shareprice": 12.25,
    "fairvaluenetassetliability": 4508000,
    "lesseeoperatingleaseremainingleaseterm": "P4Y9M",
    "rouassetsandofleaseliabilities": 399000,
    "royaltiesinsalespercentage": 0.03,
    "businesscombinationrecognizedidentifiableassetsacquiredandliabilitiesassumedcontingentliability": 6303,
    "saleofstockconsiderationreceivedontransaction": 2218000,
    "saleofstocknumberofsharesissuedintransaction": 192666,
    "deferredofferingcosts": 207000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsweightedaveragevolatilityrate": 0.6824,
    "warrantsandrightsoutstanding": 3723000,
    "stockissuedduringperiodvaluenewissues": 13027000,
    "proceedsfromissuanceofprivateplacement": 232000,
    "saleofstockpricepershare": 22.29,
    "stockissuedduringperiodsharesnewissues": 2350704,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnumberofsharesavailableforgrant": 177632,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 2.93,
    "sharebasedcompensationarrangementbysharebasedpaymentawardcompensationcost1": 1584000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisesinperiodtotalintrinsicvalue": 217000,
    "israelicorporatetaxrate": 0.23,
    "operatinglosscarryforwards": 45500000,
    "otherresearchanddevelopmentexpense": 822000,
    "proceedsfromissuanceofcommonstock": 6339095,
    "sharesissued": 284317,
    "proceedsfromissuanceinitialpublicoffering": 42100000,
    "entityregistrantname": "Enlivex Therapeutics Ltd.",
    "tradingsymbol": "ENLV",
    "documenttype": "20-F",
    "currentfiscalyearenddate": "--12-31",
    "entitycommonstocksharesoutstanding": 14587934,
    "amendmentflag": "false",
    "entitycentralindexkey": 1596812,
    "entitycurrentreportingstatus": "Yes",
    "entityvoluntaryfilers": "No",
    "entityfilercategory": "Accelerated Filer",
    "entitywellknownseasonedissuer": "No",
    "documentperiodenddate": "2020-12-31",
    "documentfiscalyearfocus": 2020,
    "documentfiscalperiodfocus": "FY",
    "entityemerginggrowthcompany": "false",
    "entityshellcompany": "false",
    "entityfilenumber": "001-36578",
    "entityincorporationstatecountrycode": "L3",
    "entityaddressaddressline1": "14 Einstein Street",
    "entityaddresscityortown": "Nes Ziona",
    "entityaddresscountry": "IL",
    "entityaddresspostalzipcode": 7403618,
    "contactpersonnelname": "Mr. Oren Hershkovitz",
    "cityareacode": 972,
    "localphonenumber": 2.6208072,
    "contactpersonnelemailaddress": "Oren@enlivexpharm.com",
    "contactpersonnelfaxnumber": "+972.2.6208070",
    "security12btitle": "Ordinary Shares, par value of NIS 0.40",
    "securityexchangename": "NASDAQ",
    "entityinteractivedatacurrent": "Yes",
    "documentaccountingstandard": "U.S. GAAP",
    "documentannualreport": "true",
    "documentregistrationstatement": "false",
    "documentshellcompanyreport": "false",
    "documenttransitionreport": "false"
  },
  {
    "date": "2019-12-31",
    "symbol": "ENLV",
    "period": "FY",
    "entityregistrantname": "Enlivex Therapeutics Ltd.",
    "entitycentralindexkey": 1596812,
    "amendmentflag": "false",
    "currentfiscalyearenddate": "--12-31",
    "documenttype": "20-F",
    "documentperiodenddate": "2019-12-31",
    "documentfiscalyearfocus": 2019,
    "documentfiscalperiodfocus": "FY",
    "entitycurrentreportingstatus": "Yes",
    "entitywellknownseasonedissuer": "No",
    "entityvoluntaryfilers": "No",
    "entityemerginggrowthcompany": "false",
    "entityshellcompany": "false",
    "documentannualreport": "true",
    "documentshellcompanyreport": "false",
    "documenttransitionreport": "false",
    "entitycommonstocksharesoutstanding": 10334126,
    "entityfilercategory": "Accelerated Filer",
    "entityinteractivedatacurrent": "Yes",
    "entityincorporationstatecountrycode": "L3",
    "cashandcashequivalentsatcarryingvalue": 3948000,
    "depositsassetscurrent": 8060000,
    "prepaidexpensecurrent": 510000,
    "otherreceivablesnetcurrent": 403000,
    "cash": 1500000,
    "receivablesheldforsaleamount": 2000000,
    "assetscurrent": 16421000,
    "restrictedcashnoncurrent": 76000,
    "prepaidexpensenoncurrent": 5000,
    "propertyplantandequipmentnet": 648000,
    "otherassets": 410000,
    "assetsnoncurrent": 1139000,
    "assets": 17560000,
    "accountspayabletradecurrent": 316000,
    "accountspayableandotheraccruedliabilitiescurrent": 1897000,
    "accountspayablerelatedpartiescurrent": 367000,
    "cvrholders": 3400000,
    "liabilitiescurrent": 5980000,
    "otherlongtermdebt": 298000,
    "liabilitiesnoncurrent": 298000,
    "liabilities": 6278000,
    "commonstockvalue": 1151000,
    "additionalpaidincapital": 37104000,
    "accumulatedothercomprehensiveincomelossforeigncurrencytranslationadjustmentnetoftax": -1300000,
    "retainedearningsaccumulateddeficit": -25673000,
    "stockholdersequity": -25673000,
    "liabilitiesandstockholdersequity": 17560000,
    "commonstockparorstatedvaluepershare": 0.4,
    "commonstocksharesauthorized": 45000000,
    "commonstocksharesissued": 10334126,
    "commonstocksharesoutstanding": 10334126,
    "preferredstockparorstatedvaluepershare": 0.4,
    "preferredstocksharesauthorized": 3146815,
    "preferredstocksharesoutstanding": 525171,
    "researchanddevelopmentexpense": 5724000,
    "generalandadministrativeexpense": 2895000,
    "operatingexpenses": 8619000,
    "operatingincomeloss": -8619000,
    "othernonoperatingincome": 238000,
    "othernonoperatingexpense": 1003000,
    "netincomeloss": -9384000,
    "othercomprehensiveincomeforeigncurrencytransactionandtranslationadjustmentnetoftaxportionattributabletoparent": 951000,
    "othercomprehensiveincomelossnetoftaxportionattributabletoparent": 951000,
    "comprehensiveincomenetoftax": -8433000,
    "earningspersharebasicanddiluted": -1.11,
    "weightedaveragenumberofshareoutstandingbasicanddiluted": 8649486,
    "sharesoutstanding": 10334126,
    "stockissuedduringperiodsharesstockoptionsexercised": 2360,
    "stockissuedperiodvalueofconversionofpreferredshares": -81000,
    "stockissuedperiodsharesofconversionofpreferredshares": -4958705,
    "stockissuedperiodissuanceofexercisewarrantsvalue": 247000,
    "stockissuedperiodissuanceofexercisewarrantsshares": 20348,
    "stockissuedduringperiodissuanceofcashconsiderationofstockvalues": 7631000,
    "stockissuedduringperiodissuanceofcashconsiderationofstockshares": 682631,
    "stockissuedduringperiodissuedconjunctionofshareoptionvalue": 574000,
    "stockissuedduringperiodissuedconjunctionofshareoptionshare": 221641,
    "stockissuedduringperiodissuanceofconnectionwithmergervalue": 597000,
    "stockissuedduringperiodissuanceofconnectionwithmergershares": 420554,
    "adjustmentstoadditionalpaidincapitalsharebasedcompensationrequisiteserviceperiodrecognitionvalue": 810000,
    "cashconsideration": 8362000,
    "proceedsfromdebtnetofissuancecosts": 655000,
    "depreciation": 206000,
    "noncashoperatingleaseexpense": 168000,
    "increasedecreaseinassetretirementobligations": -7000,
    "gainlossonsaleofpropertyplantequipment": -75000,
    "sharebasedcompensation": 203000,
    "changesinvaluesofwarrantsexercisableintoshares": -51000,
    "increasedecreaseinprepaidexpense": -277000,
    "increasedecreaseinotherreceivables": -41000,
    "increasedecreaseinaccountspayabletrade": 114000,
    "increasedecreaseinaccruedliabilitiesandotheroperatingliabilities": 433000,
    "increasedecreaseinoperatingliabilities": -167000,
    "increasedecreaseinduetorelatedparties": 342000,
    "netcashprovidedbyusedinoperatingactivities": -7041000,
    "paymentstoacquirepropertyplantandequipment": 193000,
    "proceedsfromsaleofpropertyplantandequipment": 4000,
    "investmentinshorttermbankdeposits": -7714000,
    "netcashcashequivalentsandrestrictedcashreceivedinissuanceofsharesfornetassetsofbioblastpharmaltd.": 1544000,
    "netcashprovidedbyusedininvestingactivities": -6359000,
    "proceedsfromissuanceofpreferredstockpreferencestockandwarrants": 7707000,
    "proceedsfromstockoptionsexercised": 599000,
    "netcashprovidedbyusedinfinancingactivities": 8306000,
    "cashandcashequivalentsperiodincreasedecrease": -5094000,
    "effectofexchangerateoncashandcashequivalents": 826000,
    "conversionofpreferredstocktoordinaryshares": 525000,
    "conversionofsixpercentagepreferenceonpreferredstocktoordinaryshares": 2071000,
    "issuanceofordinarysharesuponexerciseofwarrants": 249000,
    "issuanceofsharestoformershareholdersofbioblastpharmaltd.": 47000,
    "assetsacquired": -2632000,
    "lessliabilitiesassumed": 3532000,
    "totalnetassets": 900000,
    "interestreceivednet": 112000,
    "othercashequivalentsatcarryingvalue": 7751000,
    "additionalcashandcashequivalent": 22629000,
    "propertyplantandequipmentstraightlinepercentage": 0.33,
    "incomelossfromcontinuingoperations": -9384000,
    "interestofcumulativepreferredstock": -198000,
    "netincomelossavailabletocommonstockholdersbasic": -9582000,
    "numberofcommonshares": 3509405,
    "stockissuedduringperiodvaluesnewissues": 518295000,
    "issuanceofsharesinconnectionwithmerger": 322617000,
    "incrementalcommonsharesattributabletocalloptionsandwarrants": 80073,
    "warrantsexercised": 15609000,
    "stockissuedduringperiodsharesconversionofunits": 4203487,
    "numberofsharesusedinpersharecomputation": 8649486,
    "foreigncurrencyexchangeratetranslation1": 3.456,
    "usdollarexchangerate": -0.078,
    "patentsrelatedcosts": 120000,
    "deferredincometaxliabilities": 635000,
    "weightedaveragenumberofsharesrelatedtooutstandingpotentialshares": 3247127,
    "interesttocummulativepreferredstock": 0.06,
    "cashandduefrombanks": 937000,
    "deposits": 3011000,
    "cashheldwithrespecttocvragreement": 1500000,
    "longtermrestrictedbankdeposits": 76000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalents": 5524000,
    "annualaverageinterestrates": 0.018,
    "propertyplantandequipmentgross": 782000,
    "accumulateddepreciationdepletionandamortizationpropertyplantandequipment": 340000,
    "vacationconvalescenceandbonusaccruals": 318000,
    "employeerelatedliabilitiescurrent": 261000,
    "shorttermoperatingleaseliabilities": 123000,
    "otheraccruedliabilitiescurrent": 1195000,
    "exchangedifferencesarisingfromtranslationtopresentationcurrency": -6000,
    "changesinvaluesofwarrantsexercisableintosharesliability": -51000,
    "fairvalueofwarrantsatissuancedate": -249000,
    "fairvalueassumptionsexpectedvolatilityrateforwarrant": 0.758,
    "fairvalueassumptionsriskfreeinterestrateforwarrant": 0.0274,
    "fairvalueassumptionsexpectedtermforwarrant": "P1M",
    "cashequivalentsatcarryingvalue": 44000,
    "prepaidexpenseandotherassetscurrent": 632000,
    "assetsheldintrustcurrent": 1500000,
    "tradepayablescurrent": 10000,
    "duetorelatedpartiescurrent": 3500000,
    "otherliabilitiescurrent": 22000,
    "assetsliabilitiesatfairvaluenet": 644000,
    "estimatedfairvalueoftotalconsiderations": 5152000,
    "adjustedpermergeragreement": 420554,
    "shareprice": 12.25,
    "fairvaluenetassetliability": 4508000,
    "operatingleaseexpense": 192000,
    "cashusedinoperatingactivities": 188000,
    "rightofuseassetsobtainedinexchangefornewoperatingleaseliabilities": 141000,
    "otherassetsrightofuseassets": 501000,
    "accumulatedamortization": 91000,
    "operatingleaserightofuseassetsnet": 410000,
    "accountspayableandaccruedliabilities": 123000,
    "otherlongtermliabilities": 298000,
    "totaloperatingleaseliabilities": 421000,
    "operatingleaseweightedaverageremainingleaseterm1": "P3Y7M28D",
    "operatingleaseweightedaveragediscountratepercent": 0.107,
    "operatingleasesfutureminimumpaymentsdueintwoyears": 172000,
    "operatingleasesfutureminimumpaymentsdueinthreeyears": 157000,
    "operatingleasesfutureminimumpaymentsdueinfouryears": 126000,
    "operatingleasesfutureminimumpaymentsdueinfiveyears": 70000,
    "operatingleasesfutureminimumpaymentsdue": 525000,
    "lessimputedinterest": -104000,
    "presentvalueofleaseliabilities": 421000,
    "rouassetsandofleaseliabilities": 399000,
    "royaltiesinsalespercentage": 0.05,
    "percentageofgrants": 1,
    "businesscombinationrecognizedidentifiableassetsacquiredandliabilitiesassumedcontingentliability": 5197000,
    "newgrantapplicationdescription": "A new grant application to the Israel Innovation Authority for funding of its clinical development program of prevention of cytokine storms and organ dysfunction associated with sepsis. On April 16, 2019, the Company’s application for grants at 50% participation of a NIS 7,668 ($2,219) plan to be executed in Israel was approved by the Israel Innovation Authority. The plan was approved for a period commencing January 1, 2019 and ending December 31, 2019.",
    "preferredstockdividendratepercentage": 0.06,
    "dividendspreferredstockcash": 2071000,
    "stockissuedduringperiodsharesnewissues": 2350704,
    "descriptionofpurchaseagreements": "The Company entered into substantially identical securities purchase agreements with certain private investors, pursuant to which the investors purchased an aggregate of 682,631 Ordinary Shares for a purchase price of $12.25 per share, totaling $8,362.",
    "adjustmentstoadditionalpaidincapitalstockissuedissuancecosts": 655000,
    "conversionofwarrants": 20348,
    "stockissuedduringperiodshareissuanceofcommonandpreferredstockseriesainconnectionwithconversionofconvertiblenotes": -2070000,
    "issuanceofpreferredstockoutstanding": 4958705,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrate": 0.0167,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrate": 0.7371,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": "P5Y",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": 15500,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodgross": 158021,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresandexpirationsinperiod": 128256,
    "stockoptionsissuedduringpremergerbioblastoption": 15500,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisablenumber": 15500,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 90.16,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 8.72,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresandexpirationsinperiodweightedaverageexerciseprice": 5.24,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexercisesinperiodweightedaverageexerciseprice": 3.77,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardpremergerbioblastoptionsinperiodweightedaverageexerciseprice": 90.17,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageexerciseprice": 3.35,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm2": "P1Y8M9D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingaggregateintrinsicvalue": 30000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsnonvestednumberofshares": 425895,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantednumberofshares": 158021,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestednumberofshares": 49019,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsnonvestedoptionsforfeitednumberofshares": 128256,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsnonvestedweightedaverageexerciseprice": 6.19,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 8.72,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedinperiodweightedaverageexerciseprice": 5.01,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeitedinperiodweightedaverageexerciseprice": 5.24,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionnonvestedweightedaverageexerciseprice": 6.27,
    "commonstockothersharesoutstanding": 15500,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnumberofsharesavailableforgrant": 490749,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 5.29,
    "sharebasedcompensationarrangementbysharebasedpaymentawardcompensationcost1": 315000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisesinperiodtotalintrinsicvalue": 1262000,
    "incomelossfromcontinuingoperationsbeforeincometaxesminorityinterestandincomelossfromequitymethodinvestments": 9384000,
    "effectiveincometaxratereconciliationatfederalstatutoryincometaxrate": 0.23,
    "othertaxexpensebenefit": 2158000,
    "incometaxreconciliationpermanentdifferences": -322000,
    "incometaxreconciliationchangeindeferredtaxassetsvaluationallowance": -1836000,
    "deferredtaxassetstaxdeferredexpensecompensationandbenefitsemployeebenefits": 136000,
    "deferredtaxassetsinprocessresearchanddevelopment": 738000,
    "deferredtaxassetsoperatinglosscarryforwards": 4744000,
    "deferredtaxassetsgross": 5595000,
    "deferredtaxassetsvaluationallowance": 5595000,
    "operatinglosscarryforwards": 20343000,
    "cashandcashequivalentsfairvaluedisclosure": 3948000,
    "investmentsfairvaluedisclosure": 8060000,
    "cashheldwithrespectstocvragreement": 1500000,
    "otherassetsfairvaluedisclosure": 76000,
    "assetsfairvaluedisclosure": 13584000,
    "researchanddevelopmentexpensespayrollandrelatedexpenses": 2259000,
    "researchanddevelopmentservices": 2682000,
    "materials": 454000,
    "researchanddevelopmentexpensespatentrelatedexpenses": 120000,
    "researchanddevelopmentexpensessharebasedcompensation": 607000,
    "researchanddevelopmentexpensesdepreciation": 198000,
    "researchanddevelopmentexpensesother": 486000,
    "researchanddevelopmentexpensesgross": 6806000,
    "researchanddevelopmentassetacquiredotherthanthroughbusinesscombinationwrittenoff": -1082000,
    "researchanddevelopmentexpenses": 5724000,
    "laborandrelatedexpense": 569000,
    "compensationtodirectors": 526000,
    "generalandadministrativeexpensesprofessionalfees": 725000,
    "othergeneralandadministrativeexpense": 145000,
    "insuranceexpense": 243000,
    "generalandadministrativeexpensessharebasedcompensation": 203000,
    "otherexpenses": 484000,
    "interestincomeother": 238000,
    "foreigncurrencytransactionlossbeforetax": 945000,
    "netchangeinfairvaluewarrants": 51000,
    "bankcommissions": 7000
  },
  {
    "date": "2018-12-31",
    "symbol": "ENLV",
    "period": "FY",
    "entityregistrantname": "Enlivex Therapeutics Ltd.",
    "entitycentralindexkey": 1596812,
    "amendmentflag": "false",
    "tradingsymbol": "ENLV",
    "currentfiscalyearenddate": "--12-31",
    "documenttype": "20-F",
    "documentperiodenddate": "2018-12-31",
    "documentfiscalyearfocus": 2018,
    "documentfiscalperiodfocus": "FY",
    "entitywellknownseasonedissuer": "No",
    "entityvoluntaryfilers": "No",
    "entitycurrentreportingstatus": "Yes",
    "entityemerginggrowthcompany": "true",
    "entityextransitionperiod": "true",
    "entityshellcompany": "false",
    "entityfilercategory": "Non-accelerated Filer",
    "entitycommonstocksharesoutstanding": 419889,
    "cashandcashequivalentsatcarryingvalue": 9736000,
    "depositsassetscurrent": 40000,
    "prepaidexpensecurrent": 288000,
    "otherreceivablesnetcurrent": 213000,
    "assetscurrent": 10277000,
    "restrictedcashnoncurrent": 56000,
    "prepaidexpensenoncurrent": 16000,
    "propertyplantandequipmentnet": 685000,
    "assetsnoncurrent": 757000,
    "assets": 11034000,
    "accountspayabletradecurrent": 173000,
    "accountspayableandotheraccruedliabilitiescurrent": 944000,
    "accountspayablerelatedpartiescurrent": 13000,
    "liabilitiescurrent": 1130000,
    "assetretirementobligationsnoncurrent": 6000,
    "otherliabilitiesnoncurrent": 192000,
    "liabilitiesnoncurrent": 198000,
    "liabilities": 1328000,
    "commonstockvalue": 396000,
    "preferredstockvalue": 59000,
    "additionalpaidincapital": 27326000,
    "accumulatedothercomprehensiveincomelossforeigncurrencytranslationadjustmentnetoftax": -2251000,
    "retainedearningsaccumulateddeficit": -16289000,
    "stockholdersequity": -2251000,
    "liabilitiesandstockholdersequity": 11034000,
    "commonstockparorstatedvaluepershare": 0.4,
    "commonstocksharesauthorized": 11861073,
    "commonstocksharesissued": 3509405,
    "commonstocksharesoutstanding": 3509405,
    "preferredstockparorstatedvaluepershare": 0.4,
    "preferredstocksharesauthorized": 3146815,
    "preferredstocksharesissued": 525171,
    "preferredstocksharesoutstanding": 525171,
    "researchanddevelopmentexpense": 4255000,
    "generalandadministrativeexpense": 1044000,
    "operatingexpenses": 5299000,
    "operatingincomeloss": -5299000,
    "othernonoperatingincome": 1060000,
    "othernonoperatingexpense": 3000,
    "netincomeloss": -4242000,
    "othercomprehensiveincomeforeigncurrencytransactionandtranslationadjustmentnetoftaxportionattributabletoparent": -748000,
    "othercomprehensiveincomelossnetoftaxportionattributabletoparent": -748000,
    "comprehensiveincomenetoftax": -4990000,
    "earningspersharebasicanddiluted": -1.4,
    "weightedaveragenumberofshareoutstandingbasicanddiluted": 3509346,
    "sharesoutstanding": 4958705,
    "stockissuedduringperiodsharesstockoptionsexercised": 61,
    "stockissuedduringperiodissuanceofpreferredstockseriesbforcashconsiderationofissuancecostsvalue": 7730000,
    "stockissuedduringperiodissuanceofpreferredstockseriescforcashconsiderationofissuancecostsvalue": 59000,
    "stockissuedduringperiodissuanceofpreferredstockseriescforcashconsiderationofissuancecostsshares": 525171,
    "adjustmentstoadditionalpaidincapitalsharebasedcompensationrequisiteserviceperiodrecognitionvalue": 1009000,
    "cashconsideration": 8249000,
    "proceedsfromdebtnetofissuancecosts": 19000,
    "depreciation": 121000,
    "sharebasedcompensation": 147000,
    "changesinvaluesofwarrantsexercisableintoshares": 132000,
    "increasedecreaseinprepaidexpense": 293000,
    "increasedecreaseinotherreceivables": 130000,
    "increasedecreaseinaccountspayabletrade": 145000,
    "increasedecreaseinaccruedliabilitiesandotheroperatingliabilities": 372000,
    "increasedecreaseinduetorelatedparties": -11000,
    "netcashprovidedbyusedinoperatingactivities": -3161000,
    "paymentstoacquirerestrictedcash": 32000,
    "paymentstoacquirepropertyplantandequipment": 461000,
    "investmentinshorttermbankdeposits": -40000,
    "netcashprovidedbyusedininvestingactivities": -533000,
    "proceedsfromissuanceofpreferredstockpreferencestockandwarrants": 5194000,
    "netcashprovidedbyusedinfinancingactivities": 5194000,
    "cashandcashequivalentsperiodincreasedecrease": 1500000,
    "effectofexchangerateoncashandcashequivalents": -769000,
    "interestreceivednet": 138000,
    "foreigncurrencyexchangerateremeasurement1": 100,
    "foreigncurrencyexchangeratetranslation1": 3.845,
    "dollarexchangerateinpoints": -0.012,
    "usdollarexchangerate": -0.015,
    "propertyplantandequipmentstraightlinepercentage": 0.33,
    "incomelossfromcontinuingoperations": -4242000,
    "interestofcumulativepreferredstock": -659000,
    "netincomelossavailabletocommonstockholdersbasic": -4901000,
    "numberofcommonshares": 3509344,
    "incrementalcommonsharesattributabletocalloptionsandwarrants": 2,
    "numberofsharesusedinpersharecomputation": 3509346,
    "monthlydepositsrate": 0.0833,
    "patentsrelatedcosts": 242000,
    "deferredincometaxliabilities": 222000,
    "weightedaveragenumberofsharesrelatedtooutstandingpotentialshares": 8638789,
    "cashandduefrombanks": 1029000,
    "deposits": 8707000,
    "annualaverageinterestrates": 0.0181,
    "propertyplantandequipmentgross": 797000,
    "accumulateddepreciationdepletionandamortizationpropertyplantandequipment": 331000,
    "vacationconvalescenceandbonusaccruals": 211000,
    "employeerelatedliabilitiescurrent": 158000,
    "liabilityforuncertaintaxpositionscurrent": 222000,
    "otheraccruedliabilitiescurrent": 353000,
    "derivativeliabilitiesnoncurrent": 192000,
    "exchangedifferencesarisingfromtranslationtopresentationcurrency": 20000,
    "changesinvaluesofwarrantsexercisableintosharesliability": 132000,
    "fairvalueassumptionsexpectedvolatilityrateforwarrant": 0.758,
    "fairvalueassumptionsriskfreeinterestrateforwarrant": 0.0274,
    "fairvalueassumptionsexpectedtermforwarrant": "P1M",
    "operatingleasesfutureminimumpaymentsduecurrent": 185000,
    "operatingleasesfutureminimumpaymentsdueintwoyears": 115000,
    "operatingleasesfutureminimumpaymentsdueinthreeyears": 97000,
    "operatingleasesfutureminimumpaymentsdueinfouryears": 83000,
    "operatingleasesfutureminimumpaymentsdueinfiveyears": 62000,
    "operatingleasesfutureminimumpaymentsdue": 542000,
    "royaltiesinsalespercentage": 0.05,
    "percentageofgrants": 1,
    "businesscombinationrecognizedidentifiableassetsacquiredandliabilitiesassumedcontingentliability": 3973000,
    "relatedpartytransactionamountsoftransaction": 50000,
    "keymanagementcompensation": 745000,
    "fairvalueattributedtoinvestorswarrants": 301000,
    "cashconsiderationnet": 50000,
    "preferredstockdividendratepercentage": 0.06,
    "dividendspreferredstockcash": 1872000,
    "stockissuedduringperiodsharesnewissues": 1835204,
    "classofwarrantorrightnumberofsecuritiescalledbywarrantsorrights": 48204,
    "investmentwarrantsexerciseprice": 6.22,
    "adjustmentsofwarrantmaturity": "P7Y",
    "adjustmentstoadditionalpaidincapitalstockissuedissuancecosts": 37000,
    "conversionofwarrants": 1,
    "convertiblepreferredstocktermsofconversion": "The warrants will expire at the earlier of 36 months from the issuance date or an Exercise Event as defined in the warrant agreements.",
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrate": 0.0255,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrate": 0.7523,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": "P6Y",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": 14185,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodgross": 33889,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresandexpirationsinperiod": 162543,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisablenumber": 169115,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 6.22,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 6.4,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexercisesinperiodweightedaverageexerciseprice": 2.69,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresandexpirationsinperiodweightedaverageexerciseprice": 4.96,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageexerciseprice": 2.89,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm2": "P9Y10M25D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsnonvestednumberofshares": 625302,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantednumberofshares": 33889,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestednumberofshares": 39335,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsnonvestedoptionsforfeitednumberofshares": 159219,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsnonvestedweightedaverageexerciseprice": 6.2,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 5.78,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedinperiodweightedaverageexerciseprice": 4.75,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeitedinperiodweightedaverageexerciseprice": 5.16,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionnonvestedweightedaverageexerciseprice": 6.2,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 5.78,
    "sharebasedcompensationarrangementbysharebasedpaymentawardcompensationcost1": 690000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisesinperiodtotalintrinsicvalue": 963000,
    "incomelossfromcontinuingoperationsbeforeincometaxesminorityinterestandincomelossfromequitymethodinvestments": 4242000,
    "effectiveincometaxratereconciliationatfederalstatutoryincometaxrate": 0.23,
    "othertaxexpensebenefit": 976000,
    "incometaxreconciliationpermanentdifferences": -237000,
    "incometaxreconciliationchangeindeferredtaxassetsvaluationallowance": -778000,
    "incometaxreconciliationtranslationdifferences": 39000,
    "deferredtaxassetstaxdeferredexpensecompensationandbenefitsemployeebenefits": 31000,
    "deferredtaxassetsinprocessresearchanddevelopment": 615000,
    "deferredtaxassetsoperatinglosscarryforwards": 2771000,
    "deferredtaxassetsgross": 3417000,
    "deferredtaxassetsvaluationallowance": 3417000,
    "operatinglosscarryforwards": 12050000,
    "cashandcashequivalentsfairvaluedisclosure": 9736000,
    "investmentsfairvaluedisclosure": 40000,
    "otherassetsfairvaluedisclosure": 56000,
    "assetsfairvaluedisclosure": 9832000,
    "debtinstrumentfairvalue": 192000,
    "financialliabilitiesfairvaluedisclosure": 192000,
    "researchanddevelopmentexpensespayrollandrelatedexpenses": 1317000,
    "researchanddevelopmentservices": 1237000,
    "researchanddevelopmentexpensespatentrelatedexpenses": 242000,
    "researchanddevelopmentexpensessharebasedcompensation": 862000,
    "researchanddevelopmentexpensesdepreciation": 121000,
    "researchanddevelopmentexpensesother": 476000,
    "researchanddevelopmentexpensesgross": 4255000,
    "laborandrelatedexpense": 525000,
    "generalandadministrativeexpensesprofessionalfees": 208000,
    "othergeneralandadministrativeexpense": 108000,
    "generalandadministrativeexpensessharebasedcompensation": 147000,
    "travelandentertainmentexpense": 57000,
    "interestincomeother": 138000,
    "foreigncurrencytransactiongainbeforetax": 790000,
    "gainlossoninvestments": 132000,
    "bankcommissions": 3000
  }
]